Literature DB >> 25944999

Inflammatory microenvironment and expression of chemokines in hepatocellular carcinoma.

Ke-Qi Han1, Xue-Qun He1, Meng-Yu Ma1, Xiao-Dong Guo1, Xue-Min Zhang1, Jie Chen1, Hui Han1, Wei-Wei Zhang1, Quan-Gang Zhu1, Hua Nian1, Li-Jun Ma1.   

Abstract

AIM: To study the inflammatory microenvironment and expression of chemokines in hepatocellular carcinoma (HCC) in nude mice.
METHODS: CBRH-7919 HCC cells were injected into the subcutaneous region of nude mice. Beginning two weeks after the challenge, tumor growth was measured every week for six weeks. The stromal microenvironment and inflammatory cell infiltration was assessed by immunohistochemistry in paired tumor and adjacent peritumoral samples, and macrophage phenotype was assessed using double-stain immunohistochemistry incorporating expression of an intracellular enzyme. A chemokine PCR array, comprised of 98 genes, was used to screen differential gene expressions, which were validated by Western blotting. Additionally, expression of identified chemokines was knocked-down by RNA interference, and the effect on tumor growth was assessed.
RESULTS: Inflammatory cell infiltrates are a key feature of adjacent peritumoral tissues with increased macrophage, neutrophil, and T cell (specifically helper and activated subsets) infiltration. Macrophages within adjacent peritumoral tissues express inducible nitric oxide synthase, suggestive of a proinflammatory phenotype. Fifty-one genes were identified in tumor tissues during the progression period, including 50 that were overexpressed (including CXCL1, CXCL2 and CXCL3) and three that were underexpressed (CXCR1, Ifg and Actb). RNA interference of CXCL1 in the CBRH-7919 cells decreased the growth of tumors in nude mice and inhibited expression of CXCL2, CXCL3 and interleukin-1β protein.
CONCLUSION: These findings suggest that CXCL1 plays a critical role in tumor growth and may serve as a potential molecular target for use in HCC therapy.

Entities:  

Keywords:  Chemokines; Gene expression profile; Hepatocellular carcinoma; PCR array; RNA interference

Mesh:

Substances:

Year:  2015        PMID: 25944999      PMCID: PMC4408458          DOI: 10.3748/wjg.v21.i16.4864

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  38 in total

Review 1.  The many faces of macrophage activation.

Authors:  David M Mosser
Journal:  J Leukoc Biol       Date:  2003-02       Impact factor: 4.962

2.  The inflammatory microenvironment of HCC - the plot becomes complex.

Authors:  Jörg Schrader; John P Iredale
Journal:  J Hepatol       Date:  2010-12-23       Impact factor: 25.083

Review 3.  Paradoxical roles of the immune system during cancer development.

Authors:  Karin E de Visser; Alexandra Eichten; Lisa M Coussens
Journal:  Nat Rev Cancer       Date:  2006-01       Impact factor: 60.716

Review 4.  NF-kappaB: key mediator of inflammation-associated cancer.

Authors:  Dara Ditsworth; Wei-Xing Zong
Journal:  Cancer Biol Ther       Date:  2004-12-15       Impact factor: 4.742

Review 5.  Targeted silencing of inhibitors of apoptosis proteins with siRNAs: a potential anti-cancer strategy for hepatocellular carcinoma.

Authors:  Gang Li; Hong Chang; Yun-Peng Zhai; Wei Xu
Journal:  Asian Pac J Cancer Prev       Date:  2013

6.  Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures.

Authors:  Marie-Caroline Dieu-Nosjean; Martine Antoine; Claire Danel; Didier Heudes; Marie Wislez; Virginie Poulot; Nathalie Rabbe; Ludivine Laurans; Eric Tartour; Luc de Chaisemartin; Serge Lebecque; Wolf-Herman Fridman; Jacques Cadranel
Journal:  J Clin Oncol       Date:  2008-09-20       Impact factor: 44.544

7.  Th1/Th2-regulated expression of arginase isoforms in murine macrophages and dendritic cells.

Authors:  M Munder; K Eichmann; J M Morán; F Centeno; G Soler; M Modolell
Journal:  J Immunol       Date:  1999-10-01       Impact factor: 5.422

8.  Progesterone and calcitriol attenuate inflammatory cytokines CXCL1 and CXCL2 in ovarian and endometrial cancer cells.

Authors:  Leyla Kavandi; Michael A Collier; Huyen Nguyen; Viqar Syed
Journal:  J Cell Biochem       Date:  2012-10       Impact factor: 4.429

9.  Nonapical and cytoplasmic expression of interleukin-8, CXCR1, and CXCR2 correlates with cell proliferation and microvessel density in prostate cancer.

Authors:  Catherine Murphy; Maryalice McGurk; Johanna Pettigrew; Alfredo Santinelli; Roberta Mazzucchelli; Patrick G Johnston; Rodolfo Montironi; David J J Waugh
Journal:  Clin Cancer Res       Date:  2005-06-01       Impact factor: 12.531

10.  [Inhibition action of bufalin on human transplanted hepatocellular tumor and its effects on expressions of Bcl-2 and Bax proteins in nude mice].

Authors:  Wei Gu; Ke-qi Han; Yong-hua Su; Xue-qiang Huang; Chang-quan Ling
Journal:  Zhong Xi Yi Jie He Xue Bao       Date:  2007-03
View more
  8 in total

1.  Resveratrol inhibits hepatocellular carcinoma progression driven by hepatic stellate cells by targeting Gli-1.

Authors:  Yu Yan; Cancan Zhou; Jie Li; Ke Chen; Guanghui Wang; Guangbing Wei; Mingwei Chen; Xuqi Li
Journal:  Mol Cell Biochem       Date:  2017-04-28       Impact factor: 3.396

2.  Role of the stromal cell derived factor-1/CXC chemokine receptor 4 axis in the invasion and metastasis of lung cancer and mechanism.

Authors:  Yun Zeng; Xinwei Wang; Bijian Yin; Guohao Xia; Zhengjie Shen; Wenzhe Gu; Mianhua Wu
Journal:  J Thorac Dis       Date:  2017-12       Impact factor: 2.895

3.  Serum levels of inflammatory markers CRP, ESR and albumin in relation to survival for patients with hepatocellular carcinoma.

Authors:  Hikmet Akkiz; Brian I Carr; Harika G Bag; Ümit Karaoğullarından; Kendal Yalçın; Nazim Ekin; Ayşegül Özakyol; Engin Altıntaş; Hatice Y Balaban; Halis Şimşek; Ahmet Uyanıkoğlu; Ayhan Balkan; Sedef Kuran; Oğuz Üsküdar; Yakup Ülger; Burak Güney; Anil Delik
Journal:  Int J Clin Pract       Date:  2020-12-12       Impact factor: 2.503

4.  Pharmacological Blockade of Spinal CXCL3/CXCR2 Signaling by NVP CXCR2 20, a Selective CXCR2 Antagonist, Reduces Neuropathic Pain Following Peripheral Nerve Injury.

Authors:  Anna Piotrowska; Ewelina Rojewska; Katarzyna Pawlik; Grzegorz Kreiner; Agata Ciechanowska; Wioletta Makuch; Irena Nalepa; Joanna Mika
Journal:  Front Immunol       Date:  2019-09-26       Impact factor: 7.561

5.  Role of chemokines in hepatocellular carcinoma (Review).

Authors:  Dongdong Xue; Ya Zheng; Junye Wen; Jingzhao Han; Hongfang Tuo; Yifan Liu; Yanhui Peng
Journal:  Oncol Rep       Date:  2020-12-22       Impact factor: 3.906

6.  HCV Cure With Direct-Acting Antivirals Improves Liver and Immunological Markers in HIV/HCV-Coinfected Patients.

Authors:  Óscar Brochado-Kith; Isidoro Martínez; Juan Berenguer; Juan González-García; Sergio Salgüero; Daniel Sepúlveda-Crespo; Cristina Díez; Víctor Hontañón; Luis Ibañez-Samaniego; Leire Pérez-Latorre; Amanda Fernández-Rodríguez; María Ángeles Jiménez-Sousa; Salvador Resino
Journal:  Front Immunol       Date:  2021-08-23       Impact factor: 7.561

7.  A pan-cancer analysis of the prognostic and immunological role of β-actin (ACTB) in human cancers.

Authors:  Yuxi Gu; Shouyi Tang; Zhen Wang; Luyao Cai; Haosen Lian; Yingqiang Shen; Yu Zhou
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

8.  Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative-intent surgery for hepatocellular carcinoma: experience from a developing country.

Authors:  Danijel Galun; Aleksandar Bogdanovic; Jelena Djokic Kovac; Predrag Bulajic; Zlatibor Loncar; Marinko Zuvela
Journal:  Cancer Manag Res       Date:  2018-05-04       Impact factor: 3.989

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.